Medicare Enrolled

Dr. Vince Cataldo, MD

Hematology & Oncology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2006 (19 years)
NPI: 1659393395 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cataldo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cataldo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cataldo

Dr. Vince Cataldo is a hematology & oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cataldo performed 793 Medicare services across 586 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cataldo received a total of $5,619 from 60 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cataldo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 793 Medicare services $5,619 industry payments

Medicare Practice Summary

Medicare Utilization ↗
793
Medicare services
Bottom 43% in TX for hematology & oncology
586
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 332 $89 $206
Office visit, established patient (20-29 min) 219 $58 $140
New patient office visit, complex (60-74 min) 82 $157 $343
Office visit, established patient, complex (40-54 min) 58 $122 $241
Initial hospital admission, high complexity 38 $122 $336
Hospital follow-up visit, high complexity 38 $91 $172
Office visit, established patient (10-19 min) 26 $36 $73
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,619
Total received (2018-2024)
Avg $803/year across 7 years
Top 42% in TX for hematology & oncology
60
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,586 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,974
2023
$2,008
2022
$1,443
2021
$31
2020
$15
2019
$123
2018
$26

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$435
PFIZER INC.
$366
Merck Sharp & Dohme LLC
$343
GENZYME CORPORATION
$285
Celgene Corporation
$265
AstraZeneca Pharmaceuticals LP
$259
Alexion Pharmaceuticals, Inc.
$245
Daiichi Sankyo Inc.
$224
Eisai Inc.
$218
Genentech USA, Inc.
$218
E.R. Squibb & Sons, L.L.C.
$207
Myriad Genetic Laboratories, Inc.
$188
Pharmacosmos Therapeutics Inc.
$168
Janssen Biotech, Inc.
$160
Incyte Corporation
$118
Karyopharm Therapeutics Inc.
$116
Ipsen Biopharmaceuticals, Inc
$115
BeiGene USA, Inc.
$108
Pharmacyclics LLC, an AbbVie Company
$104
ABBVIE INC.
$97
Gilead Sciences, Inc.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$88
JAZZ PHARMACEUTICALS INC.
$81
Blueprint Medicines Corporation
$79
Stemline Therapeutics Inc.
$69
Lilly USA, LLC
$65
MorphoSys, US Inc.
$65
Amgen Inc.
$60
PharmaEssentia USA Corporation
$58
Bayer Healthcare Pharmaceuticals Inc.
$53
G1 Therapeutics, Inc.
$49
Regeneron Healthcare Solutions, Inc.
$46
Seagen Inc.
$45
CTI BioPharma Corp.
$35
SpringWorks Therapeutics, Inc.
$35
Progenics Pharmaceuticals, Inc.
$30
Alnylam Pharmaceuticals Inc.
$29
Astellas Pharma US Inc
$25
Exelixis Inc.
$23
Grifols USA, LLC
$22
Sobi, Inc
$21
Mirati Therapeutics, Inc.
$21
ARRAY BIOPHARMA INC
$20
GlaxoSmithKline, LLC.
$20
Taiho Oncology, Inc.
$19
Tempus AI, Inc
$19
Azurity Pharmaceuticals, Inc.
$18
SERVIER PHARMACEUTICALS LLC
$17
TAIHO ONCOLOGY, INC.
$17
Veracyte, Inc.
$17
Genmab U.S., Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Coherus Biosciences Inc.
$15
Tactile Systems Technology Inc
$15
Puma Biotechnology, Inc.
$15
EMD Serono, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Kite Pharma, Inc.
$14
Seattle Genetics, Inc.
$12
EISAI INC.
$12
Top 3 companies account for 20.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · Columvi · DARZALEX · DOPTELET · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · Enhertu · Flexitouch Plus · GAZYVA · GIVLAARI · Gamunex-C · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PYLARIFY · Phesgo · Pomalyst · REBLOZYL · ROLVEDON · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TASIGNA · TECVAYLI · TUKYSA · Tecentriq · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · Vonjo · WELIREG · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $709 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
202
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cataldo is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cataldo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cataldo performed 332 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cataldo receive payments from pharmaceutical companies?
Yes. Dr. Cataldo received a total of $5,619 from 60 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cataldo's costs compare to other hematology & oncology specialists in Houston?
Dr. Cataldo's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cataldo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →